Urinary Obstruction Treatment & Management

  • Author: Michael A Policastro, MD; Chief Editor: Erik D Schraga, MD   more...
 
Updated: Apr 19, 2011
 

Prehospital Care

Pulmonary edema as a consequence of renal failure from complete urinary obstruction should be treated conventionally. Partial obstruction can cause significant defects in salt and water retention, resulting in hypovolemia, which responds to standard fluid administration protocols.

Next

Emergency Department Care

Prior to addressing the specific therapy for obstruction, the ED physician must investigate and begin treatment of the life-threatening complications of obstructive uropathy (eg, pulmonary edema, hypovolemia, urosepsis, hyperkalemia).

The overriding goal in the treatment of urinary obstruction is the reestablishment of urinary flow. As stated previously, the longer the obstruction exists, the lower the rate of renal recovery and the lower the GFR if any recovery occurs.

Once urinary obstruction is entertained in the differential diagnosis, a transurethral bladder catheter should be placed. A properly positioned Foley catheter can be diagnostic as well as therapeutic for obstruction below the level of the bladder. If no urine is obtained, the proper placement of the Foley should be tested by catheter irrigation. If fluid returns freely, the catheter tip is probably in the bladder and obstruction above the bladder should be investigated. If a question still remains, imaging studies such as radiography and ultrasonography also may be used to establish proper Foley placement.

If a large PVR volume is noted, obstruction below the bladder should be investigated. Catheter drainage should then be maintained until the etiology of the obstruction is treated appropriately. Intermittent clamping of the Foley is recommended to prevent symptoms of hypotension and hematuria often ascribed to rapid bladder decompression.

Hypotension after bladder decompression is thought to be due to a vagolytic response from a rapid change in bladder-wall tension.

In a series of patients with obstruction, Christensen et al found a 50% decrease in intravesical pressure after only the first 100 mL of urine was removed.[2] Since the major drop in bladder pressure occurred with the early removal of relatively small amounts of urine, they concluded that fractionating urine removal in bladder obstruction was unjustified.

Hematuria and bladder spasm is another well-known complication of bladder decompression. Gould et al compared the incidence of hematuria in rapidly emptied and gradually emptied obstructed dog bladders.[3] They found that hematuria was correlated strongly with the degree of bladder wall damage prior to relief of obstruction and was not correlated with the rate of emptying.

Urine should be drained completely and rapidly from an obstructed bladder. Prolonged urine stasis only predisposes the patient to UTI, urosepsis, and renal failure.

Calculi are the most common causes of unilateral ureteral obstruction. More than 90% of renal calculi less than 5.0-7.0 mm in size pass spontaneously. Obstruction in these cases can be treated conservatively with intravenous fluids and analgesia. Surgical drainage is necessary only for patients with unrelenting pain, UTI, or persistent obstruction.

Position of the stone in the ureter determines the preferred method of removal. Calculi in the renal pelvis and proximal ureter are amenable to nephroscopy and removal under direct visualization. Percutaneous nephrostomy drainage is used for midureteral stones. Distal ureter stones can be removed cystoscopically by the use of a loop or basket. Extracorporeal shock wave lithotripsy is another viable option for stones in any position in the ureter.

Bilateral obstruction of the ureters is almost always an asymmetric process. Generally, whatever the etiology of ureteral obstruction, one ureter is obstructed slowly and asymptomatically over a long period of time. Not until the second ureter is obstructed are symptoms of renal failure, hyperkalemia, or acidosis observed. In this condition, radionucleotide scanning can be helpful in identifying the most viable kidney for drainage.

For midureteral or proximal ureteral obstruction, percutaneous nephrostomy tube placement is indicated.

For distal obstruction, cystoscopic placement of a ureteral stent can be attempted.

Cases of renal recovery have been detected by radionucleotide scan in kidneys without renal blood flow.

In case of suspected urosepsis from bilateral ureteral obstruction, bilateral percutaneous nephrostomy tubes must be placed to ensure that both potentially infected systems are drained.

Intrarenal obstruction secondary to crystals or protein casts is not amenable to surgical drainage. Maintenance of adequate hydration to promote high rates of urine output to dilute crystals and casts is the main treatment.

Previous
Next

Consultations

  • Consult a urologist when a transurethral catheter cannot provide adequate bladder drainage. Filiform catheters or a suprapubic cystotomy may be required to drain the bladder completely. Invasive pyelography for higher-level obstructions can be diagnostic and therapeutic.
  • Consult a nephrologist to provide emergent hemodialysis if necessary.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Michael A Policastro, MD  Assistant Professor of Emergency Medicine, Fellow in Medical Toxicology, Department of Emergency Medicine, University of Cincinnati; Consulting Staff, Department of Emergency Medicine, Jewish Hospital, Health Alliance

Michael A Policastro, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

Richard H Sinert, DO  Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Pilar Guerrero, MD  Assistant Professor, Department of Emergency Medicine, John H Stroger Jr Hospital, Cook County Hospital

Disclosure: Nothing to disclose.

Specialty Editor Board

David S Howes, MD  Professor of Medicine and Pediatrics, Section Chief and Emergency Medicine Residency Program Director, University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine

David S Howes, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Richard H Sinert, DO  Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Erik D Schraga, MD  Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

Disclosure: Nothing to disclose.

References

  1. de la Rosette JJ, Witjes WP, Schafer W, et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn. 1998;17(2):99-108. [Medline].

  2. Christensen J, Ostri P, Frimodt-Moller C, Juul C. Intravesical pressure changes during bladder drainage in patients with acute urinary retention. Urol Int. 1987;42(3):181-4. [Medline].

  3. Gould F, Cheng CY, Lapides J. Comparison of rapid versus slow decompression of the distended urinary bladder. Investigative urology. Sep 1976;14 (2):156-8. [Medline].

  4. Bartosh SM. Medical management of pediatric stone disease. Urol Clin North Am. Aug 2004;31(3):575-87, x-xi. [Medline].

  5. Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. Feb 12 1981;304(7):373-80. [Medline].

  6. Becker A, Baum M. Obstructive uropathy. Early Hum Dev. Jan 2006;82(1):15-22. [Medline].

  7. Belal M, Abrams P. Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol. Jul 2006;176(1):22-8. [Medline].

  8. Berrocal T, Lopez-Pereira P, Arjonilla A, Gutierrez J. Anomalies of the distal ureter, bladder, and urethra in children: embryologic, radiologic, and pathologic features. Radiographics. Sep-Oct 2002;22(5):1139-64. [Medline].

  9. Bosniak MA, Megibow AJ, Ambos MA, et al. Computed tomography of ureteral obstruction. AJR Am J Roentgenol. Jun 1982;138(6):1107-13. [Medline].

  10. Catalano C, Pavone P, Laghi A, et al. MR pyelography and conventional MR imaging in urinary tract obstruction. Acta Radiol. Mar 1999;40(2):198-202. [Medline].

  11. Chapple CR, Baert L, Thind P, et al. Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. Eur Urol. 1997;32(4):462-70. [Medline].

  12. Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr. Apr 2006;18(2):153-60. [Medline].

  13. Chu J. Genitourinary principles. In: Goldfrank's Toxicologic Emergencies. 8th ed. 2006: 442-56.

  14. Dal Canton A, Corradi A, Stanziale R, et al. Glomerular hemodynamics before and after release of 24-hour bilateral ureteral obstruction. Kidney Int. Apr 1980;17(4):491-6. [Medline].

  15. Dalgic A, Boyvat F, Karakayali H, et al. Urologic complications in 1523 renal transplantations: The Baskent University experience. Transplant Proc. Mar 2006;38(2):543-7. [Medline].

  16. De Luca GC, Wijdicks EF. Images in clinical medicine. Agitation associated with acute bladder obstruction. N Engl J Med. Oct 21 2010;363(17):1656. [Medline].

  17. Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med. Apr 2006;12(4):398-400. [Medline].

  18. Djavan B, Marberger M. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol. 1999;36(1):1-13. [Medline].

  19. Feinfeld DA, Anthony VL. Renal principles. In: Goldfrank's Toxicologic Emergencies. 8th ed. 2006: 427-42.

  20. Gustilo-Ashby AM, Jelovsek JE, Barber MD, et al. The incidence of ureteral obstruction and the value of intraoperative cystoscopy during vaginal surgery for pelvic organ prolapse. Am J Obstet Gynecol. May 2006;194(5):1478-85. [Medline].

  21. Hoffman LM, Suki WN. Obstructive uropathy mimicking volume depletion. JAMA. Nov 1 1976;236(18):2096-7. [Medline].

  22. Ilbeigi P, Lombardo S, Sadeghi-Nejad H. Unusual cause of obstructive uropathy. Int Urol Nephrol. 2005;37 (3):505-6. [Medline].

  23. Kessler TM, Gerber R, Burkhard FC, et al. Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study?. J Urol. Jun 2006;175(6):2170-3. [Medline].

  24. Kilby MD, Daniels JP, Khan K. Congenital lower urinary tract obstruction: to shunt or not to shunt?. BJU Int. Jan 2006;97(1):6-8. [Medline].

  25. Levin RM, Longhurst PA, Whitbeck C, Korstanje C. The effect of tamsulosin on the response of the rabbit bladder to partial outlet obstruction. Neurourol Urodyn. 2006;25(1):89-94. [Medline].

  26. Louca G, Liberopoulos K, Fidas A, et al. MR urography in the diagnosis of urinary tract obstruction. Eur Urol. Feb 1999;35(2):102-8. [Medline].

  27. Matlaga BR, Assimos DG. Urologic manifestations of nonurologic disease urolithiasis. Urol Clin North Am. Feb 2003;30(1):91-9. [Medline].

  28. Misseri R, Rink RC, Meldrum DR, Meldrum KK. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. Jun 15 2004;119(2):149-59. [Medline].

  29. Moudouni SM, Tligui M, Doublet JD, et al. Laparoscopic excision of seminal vesicle cyst revealed by obstruction urinary symptoms. Int J Urol. Mar 2006;13(3):311-4. [Medline].

  30. O'Reilly PH, Lawson RS, Shields RA, Testa HJ. Idiopathic hydronephrosis--the diuresis renogram: a new non-invasive method of assessing equivocal pelvioureteral junction obstruction. J Urol. Feb 1979;121(2):153-5. [Medline].

  31. Powers TA, Grove RB, Bauriedel JK, et al. Detection of obstructive uropathy using 99mtechnetium diethylenetriaminepentaacetic acid. J Urol. Nov 1980;124(5):588-92. [Medline].

  32. Reynard JM. Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?. Curr Opin Urol. Jan 2004;14(1):13-6. [Medline].

  33. Rodriguez RA. Renal toxicology. In: Occupational & Environmental Medicine. 2nd ed. 1997: 355-67.

  34. Rose JG, Gillenwater JY. Pathophysiology of ureteral obstruction. Am J Physiol. Oct 1973;225(4):830-7. [Medline].

  35. Rugo HS, Fischman ML. Occupational cancer. In: Occupational & Environmental Medicine. 2nd ed. 1997: 235-70.

  36. Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure?. J Urol. Mar 2005;173(3):691-6. [Medline].

  37. Tsai JD, Huang FY, Lin CC, et al. Intermittent hydronephrosis secondary to ureteropelvic junction obstruction: clinical and imaging features. Pediatrics. Jan 2006;117(1):139-46. [Medline].

  38. Wille-Gussenhoven MJ, de Bock GH, de Beer-Buijs MJ, et al. Prostate symptoms in general practice: seriousness and inconvenience. Scand J Prim Health Care. Mar 1997;15(1):39-42. [Medline].

  39. Woderich R, Fowler CJ. Management of lower urinary tract symptoms in men with progressive neurological disease. Curr Opin Urol. Jan 2006;16(1):30-6. [Medline].

  40. Zeidel ML, Pirtskhalaishvili G. Urinary tract obstruction. In: Brenner & Rector's The Kidney. 7th ed. 2004.

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.